FSCN1 and gastric cancer: In addition, the β-catenin-T cell factor (TCF; TF) signaling pathway is involved in the regulation of FSCN1 transcription in human colorectal cancer cells,81 whereas galectin-3 enhances the expression of FSCN1 in human gastric cancer cells by regulating the glycogen synthase kinase 3 (GSK)-3β/β-catenin/TCF-4 signaling pathway.92